Analyst Price Target is $2.75
▲ +50.27% Upside Potential
This price target is based on 2 analysts offering 12 month price targets for Rite Aid in the last 3 months. The average price target is $2.75, with a high forecast of $4.50 and a low forecast of $1.00. The average price target represents a 50.27% upside from the last price of $1.83.
Current Consensus is
The current consensus among 2 investment analysts is to sell stock in Rite Aid. This Sell consensus rating has held steady for over two years.
Rite Aid Corp. engages in the ownership and management of retail drug stores. It operates through the Retail Pharmacy and Pharmacy Services segments. The Retail Pharmacy segment includes branded and generic prescription drugs, health and beauty aids, personal care products, and walk-in retail clinics. The Pharmacy Services segment offers transparent and traditional pharmacy benefit management for insurance companies, employers, health plans, and government employee groups. The company was founded by Alex Grass on September 12, 1962 and is headquartered in Philadelphia, PA.